Skip to content
Clinical Trial Events
SCOPE Europe 2024

Fireside chat Patient Engagement and Recruitment track

The FDA's Revised Draft Guidance on Clinical Trial Diversity

Tue, Oct 29, 2024 · 2:40–3:05 PM CET InterContinental Barcelona

About this session

Session: ADVANCING INCLUSIVE RESEARCH: DIVERSITY PLANNING, COMMUNITY ENGAGEMENT & SITE ENABLEMENT

Join this engaging Fireside Chat to delve into the latest insights on the FDA's requirements for Diversity Action Plans. We'll discuss the implications for sponsors and explore effective strategies to ensure diverse populations are recruited for clinical trials. Gain an understanding of the process for creating and submitting a plan to the FDA, while navigating the uncertainties surrounding FDA expectations and feedback. Engage in thoughtful discussions on involving individuals impacted by the disease in clinical trials, and examine the challenges and improvements in plan submissions.

Speaker